FREMONT, Calif. -- NIDEK Inc. announced it received FDA marketing clearance for commercial release of its new MC-300 Multicolor Laser Photocoagulator System.
The MC-300 laser system, for retinal applications, disease treatments and management, has been commercially available in international markets and has received strong reviews and clinical results from retinal specialists in Asia and Europe, the company said.

"The NIDEK MC-300 is an outstanding laser for retinal applications, delivering a suite of advanced technologies to the retinal specialist,” commented Hideo Ozawa, president and founder of NIDEK, at a recent product release event. “With the introduction of the MC-300, NIDEK continues its long-standing commitment to delivering advanced solutions for all specialties of ophthalmology, including retinal applications," he said.

With worldwide operations headquartered in Gamagori, Japan, NIDEK develops, manufactures and sells laser systems and diagnostic equipment of ophthalmology, optometry, general surgery, gynecology and cosmetic dermatological surgery. NIDEK distributes its products through a network of distribution partners and a direct sales force.